Skip to main content

Kesimpta Prices, Coupons and Patient Assistance Programs

Kesimpta (ofatumumab) is a member of the CD20 monoclonal antibodies drug class and is commonly used for Multiple Sclerosis.

Kesimpta Prices

The cost for Kesimpta subcutaneous solution (20 mg/0.4 mL) is around $7,447 for a supply of 0.4 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

This Kesimpta price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Subcutaneous Solution

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Kesimpta Coupons and Rebates

Kesimpta offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Kesimpta $0 Access Card: Eligible commercially insured patients may pay as little as $0 per prescriptions when enrolled in the program; $18,000 maximum savings per calendar year; for more information contact the program at 855-537-4678.

Applies to:
Kesimpta
Number of uses:
per prescription per calendar year

Form more information phone: 855-537-4678 or Visit website

Kesimpta Access Bridge Program: Eligible commercially insured patients who receive an initial denial for coverage may receive up to 12 months of free product while coverage is pursued; for more information contact the program at 855-537-4678.

Applies to:
Kesimpta
Number of uses:
For up to a year

Form more information phone: 855-537-4678 or Visit website

Patient Assistance Programs for Kesimpta

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: Novartis Patient Assistance Foundation, Inc. (NPAF)

Elligibility requirements:
  1. Contact program for details.
  2. At or below 600% of FPL
  3. Not specified
  4. The patient must reside in the US, Puerto Rico or the USVI.
  5. For Focalin XR, Clozaril, and Ritalin LA, Clozarila pharmacy card will be issued. All other medication will be shipped directly to the patient, unless otherwise noted. *Additional products may be available. Please contact the program for a complete product listing. www.pap.novartis.com
Applicable drugs:
  • Kesimpta (ofatumumab) Injection; Subcutaneous

More information please phone: 800-277-2254 Visit Website

Provider: Patient Access Network Foundation (PAN)

Elligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Kesimpta (ofatumumab) Injection; Subcutaneous

More information please phone: 866-316-7263 Visit Website

Provider: Alongside KESIMPTA Program

Elligibility requirements:
  1. Contact program for details.
  2. Determined case by case
  3. Medically Necessary as determined by a Doctor
  4. US residency requirements are not specified.
  5. Co-payment assistance, patient support, and patient assistance programs are available for eligible patients.
Applicable drugs:
  • Kesimpta (ofatumumab) Injection; Subcutaneous

More information please phone: 855-537-4678 Visit Website